Purchase this article with an account.
E Yoles, M Zalish, V Lavie, R Duvdevani, S Ben-Bassat, M Schwartz; GM1 reduces injury-induced metabolic deficits and degeneration in the rat optic nerve.. Invest. Ophthalmol. Vis. Sci. 1992;33(13):3586-3591.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
This study demonstrates the earliest reported effects of GM1 treatment on crush-injured axons of the mammalian optic nerve. GM1, administered intraperitoneally immediately after injury, was found to reduce the injury-induced metabolic deficit in nerve activity within 2 hr of injury, as measured by changes in the nicotine-amine adenine dinucleotide redox state. After 4 wk, transmission electron microscopy 1 mm distal to the site of injury revealed a sevenfold increase in axonal survival in GM1-treated compared to untreated injured nerves. These results emphasize the beneficial effect of GM1 on injured optic nerves as well as the correlation between immediate and long-term consequences of the injury. Thus, these results have implications for treating damaged optic nerves.
This PDF is available to Subscribers Only